He has a family.
A future.
Diet. Exercise. Annual checkups.
He did everything right.
Inside his arteries
His cholesterol was “normal.”
His arteries were not.
50% of heart attacks happen to people with “normal” cholesterol
Standard tests missed it.
Lipid Profiling
ApoB and Lp(a) provide the resolution traditional LDL panels lack.
Your cholesterol may be normal.
That doesn't mean it's low enough.
Standard lipid panels are archaic. We measure ApoB - the true driver of atherosclerosis - and Lp(a), a genetic risk factor most doctors never check. If you have any detectable plaque, “normal” is no longer the target.
Advanced Pharmacology
Better medications exist now.
Most people just aren't offered them.
Clinical guidelines are a decade behind pharmaceutical reality. We utilize the frontier of FDA-approved therapies - PCSK9 inhibitors, Inclisiran, and bempedoic acid - before the standard system considers you “sick enough” for them.
Our Methodology
The Preval Approach
Measure What Matters
Beyond LDL. We deploy advanced lipid panels and CCTA imaging to see exactly what is happening inside your vessel walls.
Prescribe What Works
We don't wait for a cardiovascular event. We use clinical-grade pharmacology to drop risk markers to physiological minimums.
Treat to Target
We iterate every 90 days. If the data hasn't moved, the protocol changes. We do not accept "good enough."
Beyond Bloodwork: Visualization
Blood tells a story, but imaging shows the reality. We utilize CAC and CCTA (AI-enabled CT angiography) to map plaque volume, density, and stability. We don't guess - we see.
Why a Specialist?
New data and treatment options emerge faster than any general practice can track. Our entire focus is prevention - staying current so your treatment always reflects the latest evidence.
The Guideline Gap
How Preval compares to the standard of care.
Lipid Screening
Standard LDL-C
Comprehensive ApoB / Lp(a)
Intervention Threshold
Wait for 10-year risk score
Immediate correction of drivers
Medication Philosophy
Generic statins only
Multi-modal advanced therapies
Imaging
Never (reactive)
Serial CCTA (proactive)
| Metric | Standard Care | Preval |
|---|---|---|
| Lipid Screening | Standard LDL-C | Comprehensive ApoB / Lp(a) |
| Intervention Threshold | Wait for 10-year risk score | Immediate correction of drivers |
| Medication Philosophy | Generic statins only | Multi-modal advanced therapies |
| Imaging | Never (reactive) | Serial CCTA (proactive) |
Your Path to Reduced Risk
Risk Assessment
Upload existing labs or we order advanced lipid testing including ApoB and Lp(a).
Expert Consultation
Video visit with a cardiology-trained provider to review your full risk picture.
Prescription Plan
Get the right medications at the right doses. Not "wait and see" - act now.
Optimization
Follow-up testing and dose adjustments every 90 days until optimal levels are achieved.
The Investment in
Absence.
The cost of prevention is a fraction of the cost of a cardiac event. One consultation. Expert prescriptions. Ongoing optimization.
Early Access
Reserve Your Place
We are gradually rolling out services and accepting a limited number of patients as we fine-tune logistics. Join the waitlist to be among the first.